Signalife Video Link to AHA Demonstration of Fidelity 100

GREENVILLE, S.C., Nov. 27 /PRNewswire-FirstCall/ -- Signalife, Inc. ("Company"), (AMEX: SGN) astonished participants at the AHA when Athletes for Life Founder Willie Gault performed a "sprinting" treadmill test while garnering a diagnostic quality ECG. Pamela Bunes commented by saying, "We have more to come," as people from all over the conference came to witness, firsthand the demonstration of the Fidelity 100.

Please use the following link to view the video. http://www.signalife.com/Pages/News2006.html About Signalife, Inc.

Signalife, Inc. engages in the research, development, and marketing of signal-monitoring devices for detecting diseases. It primarily offers patient modules that are used as part of a heart monitor system to acquire, amplify, and process physiological signals associated with a patient's cardiovascular system. Signalife is based in Greenville, South Carolina. For more information visit http://www.signalife.com/.

Caution Regarding Forward-Looking Statements

Statements in this release that are not strictly historical are "forward- looking" statements. Forward-looking statements involve known and unknown risks, which may cause Signalife's actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to, failure to complete the development and introduction of heart monitoring and other biomedical devices incorporating Signalife's technology, failure to obtain federal or state regulatory approvals governing heart monitoring and other biomedical devices incorporating Signalife's technology, inability to obtain physician, patient, client or insurance acceptance of for heart monitoring and other biomedical incorporating Signalife's technology, and the unavailability of financing to complete management's plans and objectives, including the development of heart monitoring and other biomedical incorporating Signalife's technology. Additional risks are found in clientele acceptance of Signalife's product-set. These risks are qualified in their entirety by cautionary language and risk factors set forth and to be further described in Signalife's filings with the Securities and Exchange Commission, but are significant and should be carefully evaluated by any and all investors.